NCT02641639 2025-03-24
FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer
Mateon Therapeutics
Phase 2/3 Terminated
Clinical Trials
4 trialsNCT04209868 2024-03-29
ParaSOL
Guy's and St Thomas' NHS Foundation Trust
Phase 2/3 Recruiting
NCT04741880 2021-07-30
ELSA
Instituto Nacional de Cancer, Brazil
Phase 2/3 Unknown
NCT01379183 2016-03-21
Using Magnetic Resonance (MR) to Understand the Effect of Erythromycin on Bowel Motility
Mayo Clinic
Phase 2/3 Completed